GlassScriptPhysician profile
Gil A Martinez
NPI 1548556673
$8,398.07
in general payments reported to CMS, 2019-2025
37 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,444 · 2022: $1,085 · 2023: $1,888 · 2024: $1,793 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,661 · Travel and Lodging: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,660.78 |
| Travel and Lodging | $208.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,568.78 | 2021-2025 | |
| Forte Bio-Pharma LLC | $958.81 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $753.60 | 2025 | Intracept |
| Collegium Pharmaceutical, INC. | $617.28 | 2021-2025 | Xtampza, Belbuca |
| Scilex Pharmaceuticals INC. | $563.28 | 2021-2025 | Ztlido, Elyxyb |
| Biohaven Pharmaceuticals, INC. | $444.93 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $384.70 | 2021-2025 | Relistor |
| Merck Sharp & Dohme LLC | $355.25 | 2021-2023 | Belsomra |
| Pfizer INC. | $353.50 | 2021-2024 | |
| Nevro Corp. | $352.90 | 2021-2024 | Senza |
| Valinor Pharma, LLC | $283.39 | 2023-2025 | Movantik |
| Eisai INC. | $231.55 | 2021-2022 | |
| Abbott Laboratories | $178.05 | 2021 | |
| Redhill Biopharma INC. | $170.43 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $121.01 | 2022-2024 | Trintellix |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gil Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.